Rankings
▼
Calendar
OCGN (Ocugen, Inc.) Stock Financials & Earnings | Market Cap Arena
OCGN
Ocugen, Inc.
Mkt Cap
$578M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$4M
Net Income (TTM)
-$68M
EPS (TTM)
-$0.23
Free Cash Flow (TTM)
-$57M
Gross Margin
45.9%
Op. Margin
-1425.7%
Net Margin
-1537.4%
FCF Margin
-1295.0%
P/S Ratio (TTM)
130.9x
P/E Ratio (TTM)
—
YoY Rev Growth
+8.8%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$443K
-$10M
-$18M
Q2 23
$485K
-$14M
-$24M
Q3 23
$4M
-$3M
-$12M
Q4 23
$6M
$6M
-$9M
Q1 24
$1M
$1M
-$12M
Q2 24
$1M
$1M
-$15M
Q3 24
$1M
$1M
-$13M
Q4 24
$764K
$764K
-$14M
Q1 25
$1M
$1M
-$15M
Q2 25
$1M
$1M
-$14M
Q3 25
$2M
$2M
-$18M
Q4 25
-$193K
-$3M
-$17M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
1304.1x
—
Q2 23
622.5x
—
Q3 23
124.9x
—
Q4 23
54.2x
—
Q1 24
51.4x
—
Q2 24
48.6x
—
Q3 24
61.9x
—
Q4 24
142.5x
—
Q1 25
127.8x
—
Q2 25
121.5x
—
Q3 25
107.6x
—
Q4 25
130.9x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$18M
-$20M
Q2 23
-$19M
-$22M
Q3 23
-$14M
-$17M
Q4 23
-$11M
-$14M
Q1 24
-$11M
-$13M
Q2 24
-$10M
-$10M
Q3 24
-$11M
-$12M
Q4 24
-$10M
-$10M
Q1 25
-$19M
-$19M
Q2 25
-$11M
-$11M
Q3 25
-$13M
-$13M
Q4 25
-$14M
-$14M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$2M
Q2 23
$3M
Q3 23
$3M
Q4 23
$3M
Q1 24
$2M
Q2 24
$513K
Q3 24
$507K
Q4 24
$13K
Q1 25
$16K
Q2 25
$43K
Q3 25
$91K
Q4 25
$35K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+2.5%
Q2 23
—
+22.8%
Q3 23
—
-30.2%
Q4 23
—
-39.3%
Q1 24
+128.9%
-28.4%
Q2 24
+135.3%
-30.9%
Q3 24
-69.3%
-10.8%
Q4 24
-87.3%
-0.4%
Q1 25
+46.1%
+20.8%
Q2 25
+20.3%
-8.6%
Q3 25
+54.2%
+34.7%
Q4 25
-125.3%
+15.1%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
607.0%
Q2 23
$3M
542.7%
Q3 23
$2M
58.8%
Q4 23
$2M
28.5%
Q1 24
$2M
173.7%
Q2 24
$2M
166.3%
Q3 24
$2M
166.5%
Q4 24
$2M
245.5%
Q1 25
$2M
127.3%
Q2 25
$2M
134.4%
Q3 25
$2M
112.7%
Q4 25
$2M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$10M
$8M
Q2 23
$15M
$9M
Q3 23
$7M
$9M
Q4 23
$10M
$5M
Q1 24
$7M
$6M
Q2 24
$9M
$8M
Q3 24
$8M
$6M
Q4 24
$8M
$6M
Q1 25
$10M
$6M
Q2 25
$8M
$7M
Q3 25
$11M
$8M
Q4 25
$11M
$6M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$68M
$8M
$77M
Q2 23
$71M
$0
$71M
Q3 23
$53M
$0
$53M
Q4 23
$39M
$0
$39M
Q1 24
$26M
$0
$26M
Q2 24
$16M
$0
$16M
Q3 24
$39M
$0
$39M
Q4 24
$59M
$0
$59M
Q1 25
$38M
$0
$38M
Q2 25
$27M
$0
$27M
Q3 25
$33M
$0
$33M
Q4 25
$19M
$0
$19M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
226M
+2.5%
Q2 23
238M
+5.7%
Q3 23
256M
+7.6%
Q4 23
257M
+0.0%
Q1 24
257M
+0.3%
Q2 24
257M
+0.0%
Q3 24
278M
+8.1%
Q4 24
291M
+4.6%
Q1 25
292M
+0.4%
Q2 25
292M
+0.0%
Q3 25
304M
+4.1%
Q4 25
312M
+2.7%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$0
42
FY 15
$0
49
FY 16
$0
47
FY 17
$0
45
FY 18
$0
49
FY 19
$0
16
FY 20
$3K
15
FY 21
$0
56
FY 22
$30K
84
FY 23
$93K
65
FY 24
$43K
95
FY 25
$14
310K
marketcaparena.com